Skip to content
value.today

Biocon Limited vs Rhythm Pharmaceuticals, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Biocon Limited is the larger company by market value: $6.4 B against $6.0 B for Rhythm Pharmaceuticals, Inc., 1.1 times as much (market caps of Nov 20, 2026 for Biocon Limited and Oct 15, 2026 for Rhythm Pharmaceuticals, Inc.).
  • Biocon Limited had more revenue: $1.8 B in the year to March 2026 against $190 M for Rhythm Pharmaceuticals, Inc. in the year to December 2025.
  • Biocon Limited made a net profit of $42 M, while Rhythm Pharmaceuticals, Inc. made a net loss of $197 M.
  • Biocon Limited keeps more of each dollar of sales: a net margin of 2.3% against -103.6% for Rhythm Pharmaceuticals, Inc.
  • Biocon Limited employs more people: 12,000 against 414 at Rhythm Pharmaceuticals, Inc. Each employee brings in about $150,988 of revenue at Biocon Limited and $458,357 at Rhythm Pharmaceuticals, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01983965947922020202120222023202420252026Biocon Limited 129Rhythm Pharmaceuticals, Inc. 599

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B2022202320242025Rhythm Pharmaceuticals, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBiocon Limited
BIOCON.BO · #2,992 in the world
Rhythm Pharmaceuticals, Inc.
RYTM · #3,141 in the world
Profile
Country🇮🇳 India🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded19782008
Size
Market cap$6.4 B$6.0 B
Revenue$1.8 B$190 M
Net income$42 M▲ best$-197 M
Employees12,000414
Valuation
P/E ratio154×—
Price to sales3.5×21.4×
Price to book1.6×43.2×
Free cash flow yield—-1.9%
Profitability
Gross margin—89.7%
Operating margin—-101.2%
Net margin—-103.6%
Return on equity—-244.4%
Growth
Revenue growth—45.8%
Revenue growth, 3 years a year—100.2%
Financial strength
Debt to equity—0.7×
Cash
Free cash flow margin—-61.5%
Strength scores
Piotroski F-score—6 of 9
Altman Z-score zone—safe
Data as ofMarket cap Nov 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Biocon Limited or Rhythm Pharmaceuticals, Inc.?

Biocon Limited is the larger company by market value: $6.4 B against $6.0 B for Rhythm Pharmaceuticals, Inc., 1.1 times as much (market caps of Nov 20, 2026 for Biocon Limited and Oct 15, 2026 for Rhythm Pharmaceuticals, Inc.).

Which makes more money, Biocon Limited or Rhythm Pharmaceuticals, Inc.?

Biocon Limited had more revenue: $1.8 B in the year to March 2026 against $190 M for Rhythm Pharmaceuticals, Inc. in the year to December 2025. Biocon Limited made a net profit of $42 M, while Rhythm Pharmaceuticals, Inc. made a net loss of $197 M.

Which is more profitable, Biocon Limited or Rhythm Pharmaceuticals, Inc.?

Biocon Limited keeps more of each dollar of sales: a net margin of 2.3% against -103.6% for Rhythm Pharmaceuticals, Inc.

Which has more employees, Biocon Limited or Rhythm Pharmaceuticals, Inc.?

Biocon Limited employs more people: 12,000 against 414 at Rhythm Pharmaceuticals, Inc. Each employee brings in about $150,988 of revenue at Biocon Limited and $458,357 at Rhythm Pharmaceuticals, Inc.